Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 1
2005 3
2006 4
2007 3
2008 3
2009 6
2010 4
2011 11
2012 13
2013 5
2014 7
2015 11
2016 16
2017 11
2018 7
2019 17
2020 9
2021 12
2022 9
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Cross-vendor multiparametric mapping of the human brain using 3D-QALAS: A multicenter and multivendor study.
Fujita S, Gagoski B, Hwang KP, Hagiwara A, Warntjes M, Fukunaga I, Uchida W, Saito Y, Sekine T, Tachibana R, Muroi T, Akatsu T, Kasahara A, Sato R, Ueyama T, Andica C, Kamagata K, Amemiya S, Takao H, Hoshino Y, Tomizawa Y, Yokoyama K, Bilgic B, Hattori N, Abe O, Aoki S. Fujita S, et al. Among authors: yokoyama k. Magn Reson Med. 2024 May;91(5):1863-1875. doi: 10.1002/mrm.29939. Epub 2024 Jan 9. Magn Reson Med. 2024. PMID: 38192263
Glymphatic System Dysfunction in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disorders: Association with Clinical Disability.
Hagiwara A, Tomizawa Y, Hoshino Y, Yokoyama K, Kamagata K, Sekine T, Takabayashi K, Nakaya M, Maekawa T, Akashi T, Wada A, Taoka T, Naganawa S, Hattori N, Aoki S. Hagiwara A, et al. Among authors: yokoyama k. AJNR Am J Neuroradiol. 2023 Dec 29;45(1):66-71. doi: 10.3174/ajnr.A8066. AJNR Am J Neuroradiol. 2023. PMID: 38123957 Free article.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
147 results